Concurrent analysis of loss of heterozygosity (LOH) and copy number abnormality (CNA) for oral premalignancy progression using the Affymetrix 10K SNP mapping array - PubMed (original) (raw)

Comparative Study

. 2004 Sep;115(4):327-30.

doi: 10.1007/s00439-004-1163-1.

Affiliations

Comparative Study

Concurrent analysis of loss of heterozygosity (LOH) and copy number abnormality (CNA) for oral premalignancy progression using the Affymetrix 10K SNP mapping array

Xiaofeng Zhou et al. Hum Genet. 2004 Sep.

Abstract

Like most human cancers, oral squamous cell carcinoma (SCC) is characterized by genetic instabilities. In this study, a single platform (Affymetrix 10K SNP mapping array) was used to generate both loss of heterozygosity (LOH) and DNA copy number abnormality (CNA) read-outs for precise and high-resolution genetic alteration profiles. As a proof of principle, we performed this concordant analysis on a panel of deletion and trisomy cell lines with known chromosomal alterations and the precise LOH and CNA regions were detected as expected. Using a previously described oral SCC progression model system, we identified a set of genomic regions that may be associated with the malignancy progression, including chromosome regions 3pter-3p35.3, 3p14.1-3p13, 11p, 11q14.3-11q22.2, and 11q13.5-11q14.1. These data show that it is feasible to utilize high-density SNP arrays to generate concordant LOH and CNA profiles at high resolution.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cancer Genet Cytogenet. 1997 Jan;93(1):10-21 - PubMed
    1. Genome Biol. 2001;2(8):RESEARCH0032 - PubMed
    1. Cancer Genet Cytogenet. 2004 May;151(1):82-4 - PubMed
    1. Nature. 1998 Dec 17;396(6712):643-9 - PubMed
    1. Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):31-6 - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources